Ranbaxy Laboratories - Pharma stock analysis

3
Ranbaxy Laboratories BSE Code : 500359 NSE Code : RANBAXY Sector : PHARMACEUTICALS Report date : Sun Apr 13 10:42:01 EDT 2014 Industry overview Market Cap Market Cap is the price of all the outstanding common shares if we were to buy it all at the current price 19828.62 Cr The benchmark company Sun Pharma in the pharmaceuticals sector is 7 times the size of Ranbaxy Laboratories Large Caps are a choice for people who want Low volatility/risk with stable returns and high liquidity 1

description

Analysis of the Ranbaxy Lab stock that is listed on BSE/NSE. Includes return ratios and piotroski scores to understand financial stability of the stocks

Transcript of Ranbaxy Laboratories - Pharma stock analysis

Page 1: Ranbaxy Laboratories - Pharma stock analysis

Ranbaxy Laboratories

BSE Code : 500359

NSE Code : RANBAXY

Sector : PHARMACEUTICALSReport date : Sun Apr 13 10:42:01 EDT 2014

Industry overview

Market CapMarket Cap is the price ofall the outstandingcommon shares if we wereto buy it all at the currentprice

19828.62 Cr

The benchmark companySun Pharma in thepharmaceuticals sector is7 times the size ofRanbaxy Laboratories

Large Caps are a choicefor people who want Lowvolatility/risk with stablereturns and high liquidity

1

Page 2: Ranbaxy Laboratories - Pharma stock analysis

Stock AnalysisGrowth Analysis

Companies that have grown historically are more likely to exibit similar growth in the future. Read

the trends in the 4 year annualized profit growth, book value growth and sales growth shown

below:

How good are the returns?

RoE is the speed at which the company might grow without sorting to additional fund raising.

RoCE is the growth speed, if the company used all the assets, including loans/preference shares.

The 2-year and 4-year values give a reasonable assurance about the growth sustenance.

KEY

KEY

2

Page 3: Ranbaxy Laboratories - Pharma stock analysis

Piotroski ScoreSeperate Winners from Losers

The Piotroski scoring system is a nine point system to determine the strength of a firm's financial

position. The score was developed by an accounting professor out of Chicago named Joseph

Piotroski. If it scores an 8 or 9, then the fundamentals are great for the stock.

Score: 4/9

3